Infectious Disease Control
SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines
* CEPI supports up to 40 mil. USD for early development of mRNA vaccine platform to SK bioscience; up to a further 100 mil. could be made available for late-stage development. * SK bioscience to secure new vaccines and establish pandemic response system * SK bioscience to enhance human healt...
2022-10-25 20:00
3340
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for Adults
GAITHERSBURG, Md., Oct. 22, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received eme...
2022-10-22 03:25
8992
Brii Biosciences Presents Promising Clinical Data to Support Ongoing Development of Novel HIV Therapeutic Candidates at IDWeek 2022
* Findings from two Phase 1 studies show both BRII-732 and BRII-778 are safe and well-tolerated * Results indicate potential for oral once-weekly, long-acting combination therapy for HIV infection, supporting continued clinical development * Additional data presented by Brii's licensing part...
2022-10-19 20:00
3463
The Grand Hamdan Award goes to two scientists in Australia
DUBAI, UAE, Oct. 19, 2022 /PRNewswire/ -- According to an official announcement
made recently inDubai, Prof. Ian Hector Frazer and the Late Dr. Jian Zhou are
the winners of the Grand Hamdan Award for the topic of – Infectious Diseases in
the Award's 12th term (2021-2022).
2022-10-19 04:05
2236
GenScript ProBio Enters Strategic Collaboration with Hibiocy Co. Ltd, the affiliate of Rojukiss International Public Company Limited (KISS) - the leading Thai-based Beauty & Health company, for the development and manufacturing of COVITRAP™ and future new products.
SINGAPORE, Oct. 17, 2022 /PRNewswire/ -- GenScript ProBio (a global one-stop CDMO from GenScript Group) today announced a strategic collaboration with Hibiocy Co. Ltd., a private corporation based inBangkok, Thailand, to accelerate a respiratory-care medical device, COVITRAP™ which contains human...
2022-10-17 23:56
6983
World Health Summit kicks off with German Chancellor Scholz, numerous Government Officials, WHO Director-General Tedros
Global health in focus BERLIN, Oct. 17, 2022 /PRNewswire/ -- The World Health Summit 2022, the world's leading meeting for global health, began on Sunday morning inBerlin. For the first time it is co-hosted by the World Health Organization (WHO). Among the central topics are climate change and h...
2022-10-17 10:24
1763
With New Commitment, Gates Foundation Joins Call to Help End Polio
BERLIN, Oct. 17, 2022 /PRNewswire/ -- Today at the World Health Summit, the Bill & Melinda Gates Foundation announced it will commit$1.2 billion to support efforts to end all forms of polio globally. The announcement was made ahead of a key pledging moment that will be co-hosted by Germany and the...
2022-10-17 01:30
3104
Gilead and the IAS start second year of partnership to honor champions of stigma-free HIV care services in Asia and Latin America
SINGAPORE, Oct. 13, 2022 /PRNewswire/ -- Gilead Sciences, Inc. and IAS – the International AIDS Society – have renewed their Me and My Healthcare Provider partnership to expand the campaign inBrazil, Hong Kong, Mexico, South Korea and Taiwan. The collaborative partnership, now entering its second...
2022-10-13 11:10
2808
Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants
* Homologous boosting with the prototype Novavax COVID-19 vaccine induced robust antibody titers for Omicron BA.1, BA.2, and BA.5 * Study 307 (Lot Consistency) achieved its primary endpoint, showing that three vaccine lots induced a comparable immune response thereby demonstrating the consist...
2022-10-12 21:35
3865
Brii Biosciences Announces Top-line Results from Phase 1 Study of BRII-296, A Long-Acting Therapy in Development for Postpartum Depression
* Data demonstrated that a single administration of BRII-296 at 600 mg delivered a favorable pharmacokinetic profile and is safe and well-tolerated in healthy subjects * Findings suggest BRII-296 has potential to provide a safe and effective, one-time injectable treatment option to people wit...
2022-09-26 20:00
3618
Gates Foundation Announces $1.27 Billion in Health and Development Commitments to Advance Progress Toward the Global Goals
First in-person Goalkeepers event since 2019 convenes global changemakers to highlight the urgency of achieving a more equitable world by 2030 NEW YORK, Sept. 22, 2022 /PRNewswire/ -- During United Nations General Assembly week, the Bill & Melinda Gates Foundation—alongside governments, philanth...
2022-09-22 06:36
3059
MGC Pharmaceuticals Successfully Developed Herbal-inspired Products for Treatment of Long COVID and COVID-19
LONDON, Sept. 21, 2022 /PRNewswire/ -- MGC Pharmaceuticals Ltd. (LSE: MXC), (ASX: MXC), (OTC: MGCLF), is a European based bio-pharma company, focused on developing and supplying affordable (Accessible) and Ethically Produced Plant Inspired Medicines, is helping to solve the mystery of treating Lo...
2022-09-21 17:13
3829
Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem® in China to Treat Antimicrobial Resistant Infections
* Vaborem®, a patented combination of meropenem and vaborbactam, is expected to address the rising prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections inChina * The deal brings together Melinta's innovation, Menarini's cross-regional expertise in registration and market...
2022-09-20 17:00
4182
Apex Circuit (Thailand) Co., Ltd. Awarded at the Asia Responsible Enterprise Awards 2022 for 'Vaccine 100' under Health Promotion Category
SINGAPORE, Sept. 15, 2022 /PRNewswire/ -- The Asia Responsible Enterprise Awards (AREA) 2022 is pleased to honor 72 exemplary award recipients for championing ESG to build a resilient world and a sustainable future for all. The AREA is the most prominent CSR recognition program across Asia initia...
2022-09-15 16:48
3001
GILEAD SCIENCES CELEBRATES TOP RANKING BY HEPATITIS & ASIAN PATIENT GROUPS
-- In the recently published PatientView report, Gilead is ranked number one in all corporate reputation indicators by hepatitis patient groups globally -- -- Gilead also ranks first among peers in Asia by patient groups in this region -- HONG KONG, Sept. 15, 2022 /PRNewswire/ -- Gilead Sciences...
2022-09-15 10:00
2651
TikoMed's ILB(R) inhibits cell infection by coronaviruses and modulates reactive cytokine release from microglia in vitro
Adds further support for its broad-spectrum mechanism of action following other recent TBI, ALS and tropical virus studies VIKEN, Sweden, Sept. 13, 2022 /PRNewswire/ -- TikoMed today announced the inclusion in bioRxiv* of an in vitro study evaluating the ability of the company's lead drug candid...
2022-09-13 16:08
2226
German Chancellor Scholz, WHO Director-General Tedros, international ministers at World Health Summit 2022
Press accreditation open for the world's leading global health conference BERLIN, Sept. 13, 2022 /PRNewswire/ -- The World Health Summit and the World Health Organization (WHO) as co-organizer jointly invite to the world's leading global health conference. The World Health Summit 2022 fromOctober...
2022-09-13 15:50
1937
Aldatu Biosciences Adds Another Outbreak Disease to Pandemic Preparedness Portfolio
BOSTON, Sept. 13, 2022 /PRNewswire/ -- Aldatu Biosciences, a biotechnology company developing molecular diagnostic assays and products based on gold standard real-time PCR, today announced it has been awarded a$3 Million Direct-to-Phase II Small Business Innovation Research (SBIR) grant from the ...
2022-09-13 00:33
2099
The Outbreak of COVID-19 Unlocked the Demand for Antimicrobial Technologies
Innovations triggered by the pandemic are pushing industries to adopt long-lasting antimicrobial technology, says Frost & Sullivan SAN ANTONIO, Sept. 8, 2022 /PRNewswire/ -- The outbreak of COVID-19 unlocked the demand for antimicrobial technologies across sectors, finds Frost & Sullivan's recen...
2022-09-08 15:12
2266
TikoMed's drug candidate ILB® inhibited infection of human cells by Dengue, Zika and Yellow Fever viruses in vitro, providing further support for its broad spectrum mechanism of action
VIKEN, Sweden, Sept. 7, 2022 /PRNewswire/ -- TikoMed today announced the inclusion in bioRxiv* of an in vitro study examining the ability of the company's lead drug candidate ILB® to inhibit infection of human cells by four serotypes of Dengue virus (DENV1-4), two strains of Zika virus (African a...
2022-09-07 14:32
3233
Week's Top Stories
Most Reposted
TotalEnergies ENEOS Extends Solar Partnership with Ceres in Indonesia
[Picked up by 316 media titles]
2026-06-08 10:16
DayOne Secures Over 1GW Renewable Energy in Malaysia in Landmark TNB Partnership
[Picked up by 303 media titles]
2026-06-04 23:55
Amartha Initiates Coalition to Advance Financial Health for Grassroots Communities in Indonesia
[Picked up by 296 media titles]
2026-06-05 19:08
DayOne Data Centers Announces Final Closing of its Series C Equity Financing at US$4.5 Billion
[Picked up by 294 media titles]
2026-06-05 15:00Omni HR Launches Mino, the First AI Agent Built on Unified APAC HR Data
[Picked up by 284 media titles]
2026-06-08 09:00
Most Read
YY Group (NASDAQ: YYGH) Wins Prestigious HAPA Solutions Excellence Award, Validating Enterprise AI Marketplace Adoption in Southeast Asia
2026-06-05 19:37
8969
Dreame ranked No.1 in Global Robot Vacuum Sales & Revenue, according to International Data Corporation (IDC)
2026-06-05 21:05
8186
Tuniu Announces Unaudited First Quarter 2026 Financial Results
2026-06-05 18:00
7797
